Conditions: Advanced or Metastatic Solid Tumors; Triple Negative Breast Cancer (TNBC); HR+ Breast Cancer; Colon Cancer; Gastric Cancer; Hepatecellular Carcinoma; NSCLC (Advanced Non-small Cell Lung Cancer); Mesothelioma; Pancreatic Carcinoma Metastatic; Hormone Refractory Prostate Cancer; Soft Tissue Sarcomas
Interventions: Drug: SHY-ONC6
Sponsors: SHY Therapeutics
**RECRUITING NOW**
Interventions: Drug: SHY-ONC6
Sponsors: SHY Therapeutics
**RECRUITING NOW**
Source: View full study details on ClinicalTrials.gov
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.



